Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2010 | 09-2009 | 09-2008 | 09-2007 | 09-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,847 | 2,020 | 10,094 | 24,120 | 28,020 |
| Receivables | 931 | 147 | 87 | 274 | 74 |
| Other current assets | 0 | 0 | 0 | 28 | 0 |
| TOTAL | $8,132 | $2,484 | $10,561 | $25,305 | $28,776 |
| Non-Current Assets | |||||
| PPE Net | 141 | 527 | 1,245 | 1,440 | 1,271 |
| Investments And Advances | 2,000 | 2,220 | 2,445 | 0 | 0 |
| Intangibles | 2,047 | 2,363 | 2,750 | 2,939 | 4,318 |
| Other Non-Current Assets | 35 | 110 | 254 | 170 | 161 |
| TOTAL | $4,223 | $5,219 | $6,694 | $4,548 | $5,750 |
| Total Assets | $12,355 | $7,702 | $17,255 | $29,853 | $34,526 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 682 | 1,013 | 1,342 | 1,347 | 847 |
| Accrued Expenses | 686 | 444 | 1,095 | 1,025 | 678 |
| Other current liabilities | 2,409 | 161 | 479 | 393 | 1,396 |
| TOTAL | $4,276 | $2,344 | $3,726 | $2,896 | $2,920 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 500 | N/A | N/A | N/A |
| Deferred Revenues | N/A | N/A | N/A | 99 | N/A |
| Other Non-Current Liabilities | 1,183 | 0 | 500 | 653 | 934 |
| TOTAL | $N/A | $500 | $1,227 | $653 | $934 |
| Total Liabilities | $4,276 | $2,844 | $4,953 | $3,549 | $3,855 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,181 | 6,279 | 4,293 | 3,861 | 3,420 |
| Common Shares | 72 | 56 | 43 | 39 | 34 |
| Retained earnings | -110,743 | -104,969 | -85,497 | -58,407 | -28,476 |
| Other shareholders' equity | -967 | -300 | 0 | 0 | 0 |
| TOTAL | $8,078 | $4,858 | $12,303 | $26,304 | $30,671 |
| Total Liabilities And Equity | $12,355 | $7,702 | $17,255 | $29,853 | $34,526 |